Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
otssp167 maternal embryonic leucine zipper kinase NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
MYELODYSPLASTIC SYNDROME[MeSHID:D009190]
Leukemia
Myelocytic
Acute[MeSHID:D015470]
Myeloproliferative disease[MeSHID:D009196]
Chronic Lymphocytic Leukemia[MeSHID:D015451]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
Malignant neoplasm of breast[MeSHID:D001943]		 NA phase 1 inhibitor
otssp167 tyrosine-protein kinase melk NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
MYELODYSPLASTIC SYNDROME[MeSHID:D009190]
Leukemia
Myelocytic
Acute[MeSHID:D015470]
Myeloproliferative disease[MeSHID:D009196]
Chronic Lymphocytic Leukemia[MeSHID:D015451]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
Malignant neoplasm of breast[MeSHID:D001943]		 NA phase 1 unknown
otssp167 tyrosine-protein kinase melk NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
MYELODYSPLASTIC SYNDROME[MeSHID:D009190]
Leukemia
Myelocytic
Acute[MeSHID:D015470]
Myeloproliferative disease[MeSHID:D009196]
Chronic Lymphocytic Leukemia[MeSHID:D015451]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
Malignant neoplasm of breast[MeSHID:D001943]		 NA phase 1 inhibitor
otssp167 maternal embryonic leucine zipper kinase NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
MYELODYSPLASTIC SYNDROME[MeSHID:D009190]
Leukemia
Myelocytic
Acute[MeSHID:D015470]
Myeloproliferative disease[MeSHID:D009196]
Chronic Lymphocytic Leukemia[MeSHID:D015451]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
Malignant neoplasm of breast[MeSHID:D001943]		 NA phase 1 unknown
click here to return to the previous page